|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/14/20 Cell MedX Corp. 10-Q 11/30/19 65:2.2M Empire Stock Transf… Inc |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 331K
2: EX-10.53 Loan Agreement and Note Payable Dated September 4, HTML 26K
2019
3: EX-10.54 Loan Agreement and Note Payable Dated September 6, HTML 26K
2019
4: EX-10.55 Loan Agreement and Note Payable Dated September HTML 26K
16, 2019
5: EX-10.56 Loan Agreement and Note Payable Dated September HTML 26K
19, 2019
6: EX-10.57 Loan Agreement and Note Payable Dated September HTML 26K
20, 2019
7: EX-10.58 Loan Agreement and Note Payable Dated October 30, HTML 26K
2019
8: EX-10.59 Loan Agreement and Note Payable Dated October 30, HTML 26K
2019, With Rain Communications Corp.
9: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
10: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
11: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
12: EX-32.2 Certification -- §906 - SOA'02 HTML 19K
58: R1 Document and Entity Information HTML 68K
37: R2 Consolidated Balance Sheets HTML 79K
24: R3 Consolidated Balance Sheets - Parenthetical HTML 27K
46: R4 Consolidated Statements of Operations HTML 72K
57: R5 Consolidated Statement of Stockholders' Deficit HTML 57K
36: R6 Consolidated Statements of Cash Flows HTML 85K
23: R7 Organization and Nature of Operations HTML 28K
47: R8 Related Party Transactions Disclosure HTML 39K
53: R9 Inventory Disclosure HTML 24K
21: R10 Other Current Assets Disclosure HTML 22K
39: R11 Equipment Disclosure HTML 29K
54: R12 Unearned Revenue Disclosure HTML 32K
48: R13 Revenue Disclosure HTML 26K
22: R14 Notes and Advances Payable Disclosure HTML 49K
40: R15 Share Capital Disclosure HTML 53K
55: R16 Subsequent Event Disclosure HTML 22K
49: R17 Organization and Nature of Operations: Going HTML 24K
Concern (Policies)
25: R18 Related Party Transactions Disclosure: Schedule of HTML 31K
Amounts Due to Related Parties (Tables)
38: R19 Related Party Transactions Disclosure: Schedule of HTML 28K
Transactions with Related Parties (Tables)
64: R20 Equipment Disclosure: Amortization schedule for HTML 29K
the equipment (Tables)
43: R21 Unearned Revenue Disclosure: Changes to Unearned HTML 30K
Revenue (Tables)
27: R22 Revenue Disclosure: Schedule of Revenue and HTML 25K
Associated Costs (Tables)
32: R23 Notes and Advances Payable Disclosure: Schedule of HTML 41K
Short-term Loans and Advances Outstanding (Tables)
65: R24 Share Capital Disclosure: Schedule of Stock Option HTML 31K
Activity (Tables)
44: R25 Share Capital Disclosure: Schedule of Stock HTML 27K
Options Outstanding (Tables)
28: R26 Share Capital Disclosure: Schedule of Warrant HTML 26K
Activity (Tables)
33: R27 Share Capital Disclosure: Schedule of Warrant HTML 31K
Details (Tables)
63: R28 Organization and Nature of Operations: Going HTML 23K
Concern (Details)
45: R29 Related Party Transactions Disclosure: Schedule of HTML 33K
Amounts Due to Related Parties (Details)
52: R30 Related Party Transactions Disclosure: Schedule of HTML 28K
Transactions with Related Parties (Details)
60: R31 Inventory Disclosure (Details) HTML 36K
35: R32 Other Current Assets Disclosure (Details) HTML 25K
20: R33 Equipment Disclosure: Amortization schedule for HTML 30K
the equipment (Details)
51: R34 Unearned Revenue Disclosure: Changes to Unearned HTML 31K
Revenue (Details)
59: R35 Unearned Revenue Disclosure (Details) HTML 24K
34: R36 Revenue Disclosure: Schedule of Revenue and HTML 32K
Associated Costs (Details)
19: R37 Notes and Advances Payable Disclosure: Schedule of HTML 41K
Short-term Loans and Advances Outstanding
(Details)
50: R38 Notes and Advances Payable Disclosure (Details) HTML 37K
61: R39 Share Capital Disclosure (Details) HTML 39K
42: R40 Share Capital Disclosure: Schedule of Stock Option HTML 28K
Activity (Details)
62: R41 Share Capital Disclosure: Schedule of Stock HTML 30K
Options Outstanding (Details)
31: R42 Share Capital Disclosure: Schedule of Warrant HTML 27K
Activity (Details)
26: R43 Share Capital Disclosure: Schedule of Warrant HTML 32K
Details (Details)
41: R44 Subsequent Event Disclosure (Details) HTML 22K
56: XML IDEA XML File -- Filing Summary XML 104K
30: EXCEL IDEA Workbook of Financial Reports XLSX 43K
13: EX-101.INS XBRL Instance -- cmxc-20191130 XML 571K
15: EX-101.CAL XBRL Calculations -- cmxc-20191130_cal XML 63K
16: EX-101.DEF XBRL Definitions -- cmxc-20191130_def XML 251K
17: EX-101.LAB XBRL Labels -- cmxc-20191130_lab XML 436K
18: EX-101.PRE XBRL Presentations -- cmxc-20191130_pre XML 395K
14: EX-101.SCH XBRL Schema -- cmxc-20191130 XSD 108K
29: ZIP XBRL Zipped Folder -- 0001393905-20-000009-xbrl Zip 53K
| ex-10.54 |
LOAN AGREEMENT
Rain Communications Corp. (the “Lender”) with an address at 1130 West Pender Street, Unit 820, Vancouver, BC V6E 4A4, advanced USD$15,000 (the “Principal Sum”) to Cell MedX Corp. (the “Borrower”) of 123 W. Nye Ln, Suite 446, Carson City, NV 89706. The Lender advanced the funds on September 6, 2019.
The Borrower agrees to repay the Principal Sum on demand, together with interest calculated and compounded monthly at the rate of 6% per year (the “Interest”) calculated from September 6, 2019 (the “Effective Date”). The Borrower is liable for repayment of the Principal Sum, accrued Interest, and any additional costs that the Lender incurs in trying to collect the amount owed to him under the terms of this Loan Agreement.
The Borrower acknowledges that at any time, the Lender may, in its sole discretion, provide the Borrower with written instructions to convert any payment of Principal Sum, and/or Interest (together the “Convertible Amount”) into restricted units of common stock in the capital of the Borrower. The Convertible Amount will be converted into fully paid, non-assessable and, subject to the United States securities laws, restricted units of common stock in the capital of the Borrower on the terms and at a conversion price of the then current private placement offering.
The Borrower will evidence the debt and its repayment of the Principal Sum and the Interest with a promissory note in the attached for.
| LENDER |
| BORROWER |
| Rain Communications Corp. |
| Cell MedX Corp. |
|
|
|
|
| Per: |
| Per: |
|
|
|
|
|
|
|
|
| /s/ Raph Biggar |
| /s/ Yanika Silina |
| Raph Biggar, President |
| Yanika Silina, CFO |
PROMISSORY NOTE
|
Principal Amount: USD$15,000 |
FOR VALUE RECEIVED Cell MedX Corp., (the “Borrower”) promises to pay on demand to the order of Rain Communications Corp. (the “Lender”) the sum of $15,000 lawful money of the United States of America (the “Principal Sum”) together with the Interest accrued on the Principal Sum calculated from September 6, 2019 (“Effective Date”) both before and after maturity, default and judgment at the Interest Rate as defined below.
For the purposes of this promissory note, Interest Rate means 6 per cent per year. Interest at the Interest Rate must be calculated and compounded monthly not in advance from and including the Effective Date (for an effective rate of 6.2% per annum calculated monthly), and is payable together with the Principal Sum when the Principal Sum is repaid.
The Borrower may repay the Principal Sum, and the Interest in whole or in part at any time.
Any time prior to this Promissory Note being repaid the Lender may, in its sole discretion, provide the Borrower with written instructions to convert any payment of Principal Sum, and/or Interest into restricted units of common stock in the capital of the Borrower. Payments will be converted into fully paid, non-assessable and, subject to United States securities laws, restricted units of common stock in the capital of the Borrower (the “Conversion Units”) on the terms and at a conversion price of the then current private placement offering.
The Borrower waives presentment, protest, notice of protest and notice of dishonor of this promissory note.
BORROWER
Cell MedX Corp.
Per:
/s/ Yanika Silina
Yanika Silina, CFO
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 1/14/20 | |||
| For Period end: | 11/30/19 | |||
| 9/6/19 | 10-K | |||
| List all Filings | ||||